Companies / ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Nasdaq: PRQRCIK 1612940LEIDEN
Financials · FY2025 · EUR
Ownership
105.4M shares outstanding
Ownership
| Public float | 100.00% | 105,361,064 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Carreno-Gomez BegonaDirector | — | — |
de Boer Daniel AntonCEOChief Executive Officer · Director | — | — |
Filius BartDirector | — | — |
Heggie TheresaDirector | — | — |
Hom DennisChief Financial Officer | — | — |
Lawton Alison FrancesDirector | — | — |
Maier Martin AlexanderDirector | — | — |
Platenburg Gerardus JohannesChief Scientific Officer · Director | — | — |
Shannon James SamuelDirector | — | — |
Valerio DomenicoDirector | — | — |
Institutional holders 0
| Holder | Value | % of shares |
|---|---|---|
| No institutional holders on file. | ||
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).No activity matches these filters.
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Privium Fund Management B.V. | Passive13G | — |